We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 394

Avoiding medical board discipline when prescribing opiates
  • Nossaman LLP
  • USA
  • September 10 2018

There is a host of new, ever changing, and conflicting guidelines from a multitude of regulators and academic societies. This evolving and uncertain


Mandatory CURES use begins October 2, 2018
  • Nossaman LLP
  • USA
  • August 28 2018

Starting October 2, 2018, health care practitioners authorized to prescribe, order, administer, or furnish a controlled substance must query, or


DOJ Announces Settlement with Physicians Based on Pre-Signed Blank Prescriptions for Controlled Substances
  • Breazeale Sachse & Wilson LLP
  • USA
  • August 21 2018

On August 8, 2018, the U.S. Attorney’s Office for the District of Massachusetts announced that two physicians had agreed to settle allegations of


Marijuana Still Legally Risky For Non-Citizens (And Those Who Sponsor Them)
  • Seyfarth Shaw LLP
  • USA
  • August 15 2018

While marijuana possession and use continue to become legal in many U.S. states, either for strictly medicinal purposes or for any purpose at all, it


Marijuana Still Legally Risky For Non-Citizens (And Those Who Sponsor Them)
  • Seyfarth Shaw LLP
  • USA
  • August 14 2018

While marijuana possession and use continue to become legal in many U.S. states, either for strictly medicinal purposes or for any purpose at all, it


Will Federal Special Registration Exception Preempt More Stringent State Rules on Remote Prescribing of Controlled Substances?
  • Epstein Becker Green
  • USA
  • August 14 2018

The Ryan Haight Act Online Pharmacy Consumer Protection Act of 2008 (21 U.S.C. 802(54)) (the “Ryan Haight Act” or “Act”) expanded the federal


DOJ Announces Settlement with Physicians Based on Pre-Signed Blank Prescriptions for Controlled Substances
  • Breazeale Sachse & Wilson LLP
  • USA
  • August 10 2018

On August 8, 2018, the U.S. Attorney’s Office for the District of Massachusetts announced that two physicians had agreed to settle allegations of


When Is a Controlled Substance Not a Controlled Substance?
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • July 25 2018

Human Chorionic Gonadotropin is a hormone produced during pregnancy that is prescribed as part of some fertility treatments and, less legitimately


Florida Imposes new ID Requirements for Pharmacist Dispensing of Controlled Substances
  • Akerman LLP
  • USA
  • July 5 2018

The Florida Legislature passed HB 21, which imposes a number of new requirements on prescribers and pharmacists regarding controlled substance


Law Urging DEA to Promulgate Rules for “Special Registration” Likely This Summer
  • Epstein Becker Green
  • USA
  • June 18 2018

At first blush, the passage of House Bill 5483, entitled the “Special Registration for Telemedicine Clarification Act of 2018” (the “Bill”), appears